Fierce Biotech White Logo Fierce Biotech White Logo
Webinar

Navigating the Next Wave of Innovation in eCOA

ET
60 Minutes

Join Suvoda for an insightful webinar where we delve into the evolving landscape of electronic Clinical Outcome Assessment (eCOA) systems. Our expert panel will explore the latest trends in eCOA adoption and strategies tailored for increasingly complex clinical trial environments. This session will provide a comprehensive examination of industry needs around eCOA systems, highlighting opportunities for sponsors, Contract Research Organizations (CROs), sites, and patients. Attendees will gain valuable insights into the current and future state of eCOA technology, discover potential areas for further enhancement, and learn how to leverage technology effectively while minimizing complexity.

  • Explore trends in eCOA adoption and innovation.  
  • Examine industry needs around eCOA systems.
  • Discuss how developments in other eClinical technologies are impacting eCOA. 
  • Dive in on future eCOA enhancements and how to leverage technology while reducing complexity.

Speakers

Sudova-HS-Andres-11132024.png

Andrés Escallón

Andrés Escallón, the Vice President of eCOA Solutions Strategy at Suvoda, boasts over 18 years of expertise in the eCOA industry. With roots at PHT Corporation and subsequent leadership roles at ERT, Andrés has been a driving force in eCOA project and program management. Recognized as an eCOA Subject Matter Expert, he joined Suvoda in 2021 as the Vice President of eCOA Practice, building a team and seamlessly integrating eCOA functions into Suvoda’s successful IRT delivery framework. In his current role, Andrés guides Suvoda’s eCOA product and commercial strategy, provides consultative support to industry stakeholders, and serves as the face of the eCOA product, showcasing his strategic leadership in the dynamic eCOA landscape.

Jill-HS.png

Jill V. Platko, PhD

A recognized industry thought leader, Jill brings over 30 years of scientific and 15 years eCOA experience to Suvoda as Vice President of Scientific Services. Prior to Suvoda, Jill led the development of the Scientific Advisory practice at Signant Health. While there, she advised and consulted on the design of novel ePROs for epilepsy, migraine, Parkinson's, and diabetes studies. Jill also has held leadership positions with Covance and PHT Corporation. Her expertise is often sought for publications, industry consortiums, and speaking engagements. Jill earned a bachelor’s degree in biology and mathematics from SUNY, and a doctorate in genetics and development from Cornell University.

ianhs10222024.png

Ian Jennings

Ian Jennings, Executive Vice President, Enterprise eCOA Sales at Suvoda, has spent his entire 35-year career in commercial roles within the Life Science sector, focused on clinical trial solutions spanning eCOA, eConsent, IRT, EDC, CTMS, Medical Imaging, Patient Recruitment/Engagement, and Digital Patient solutions. Prior to joining Suvoda, Ian held leadership roles at Signant Health, ERT (now Clario), Exco InTouch, Parexel Informatics, ClinPhone, and PHT Corporation. Ian believes strongly in the power of people and teams to collaborate with a single focus to meet customer expectations. He is passionate about patient-facing technologies that enable clinical trial participants to better engage in their trial journey, ultimately leading to better outcomes for all stakeholders. Ian holds a BSc with Honors in Applied Chemistry from Sheffield Hallam University, UK.
 

Register here!

Date/Time:
ET
Duration:
60 Minutes